How does Novo Nordisk's unique corporate culture, with its emphasis on a communal work environment and long$-$term focus on diabetes, contribute to its success in the pharmaceutical industry?

In what ways does Novo Nordisk's foundation ownership structure impact its corporate decision$-$making, especially considering the tension between values and competitiveness mentioned by author Hanne Sindb$$k$?$

Given the challenges Novo Nordisk faces in meeting the demand for its drugs, how does the company balance the need for growth with its commitment to employee well$-$being, as reflected in its internal "value audits" and adherence to the Novo Nordisk Essentials?